Corpus StriatumDopamineChronic DiseaseMultiple SclerosisReceptors, DopamineReceptors, Dopamine D23,4-Dihydroxyphenylacetic AcidBrainAcute DiseaseMagnetic Resonance ImagingReceptors, Dopamine D1BerberineCorpus LuteumSubstantia NigraDopamine AntagonistsDopamine AgonistsCorpus CallosumReceptors, Dopamine D3Rats, Inbred StrainsRats, Sprague-DawleyDopamine Plasma Membrane Transport ProteinsDopamine AgentsNeuronsAgenesis of Corpus CallosumNeostriatumDopamine Uptake InhibitorsReceptors, Dopamine D5Dopamine beta-HydroxylaseRacloprideBasal GangliaBenzazepinesQuinpiroleNucleus AccumbensOxidopamineTyrosine 3-MonooxygenaseHaloperidolCocaineApomorphineMicrodialysisHomovanillic AcidAmphetamineCaudate NucleusSulpiridePutamenLevodopaDopamine and cAMP-Regulated Phosphoprotein 32SalicylamidesCorpora AllataBehavior, AnimalDopaminergic NeuronsRewardSpiperoneMesencephalonMotor ActivityPenisMethamphetamineNomifensineCorpus Luteum Maintenancealpha-MethyltyrosineParkinson Disease, SecondaryTime FactorsParkinsonian DisordersNeural PathwaysVentral Tegmental AreaErgolinesTropanesDihydroxyphenylalanineLuteolysisBiogenic MonoaminesProgesteroneDose-Response Relationship, DrugAnalysis of VarianceStereotyped BehaviorNerve Tissue ProteinsRats, WistarImmunohistochemistryPrefrontal CortexBrain ChemistryDisease Models, AnimalSerotoninVesicular Monoamine Transport Proteins